A2A adenosine receptor antagonists -: future drugs for Parkinson's disease?

被引：52
|
作者：
Müller, CE [1 ]
机构：
[1] Univ Bonn, Inst Pharmaceut, D-53115 Bonn, Germany
来源：
DRUGS OF THE FUTURE | 2000年 / 25卷 / 10期
关键词：
D O I：
10.1358/dof.2000.025.10.858696
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1043 / 1052
页数：10
相关论文
共 50 条
  • [1] Adenosine A2A receptor antagonists and Parkinson's disease
    Richardson, PJ
    PARKINSON'S DISEASE, 2002, 1 : 59 - 69
  • [2] Adenosine A2A Receptor Antagonists and Parkinson's Disease
    Shook, Brian C.
    Jackson, Paul F.
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (10): : 555 - 567
  • [3] Adenosine A2A receptor antagonists in the therapy of Parkinson's disease
    Morelli, M.
    Simola, N.
    Pinna, A.
    Pontis, S.
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 537 - 537
  • [4] An Overview of Adenosine A2A Receptor Antagonists in Parkinson's Disease
    Jenner, Peter
    ADENOSINE RECEPTORS IN NEUROLOGY AND PSYCHIATRY, 2014, 119 : 71 - 86
  • [5] Adenosine A2A receptor antagonists and Parkinson's disease:: State of the art and future directions
    Simola, N.
    Morelli, M.
    Pinna, A.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (15) : 1475 - 1489
  • [6] Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
    Armentero, Marie Therese
    Pinna, Annalisa
    Ferre, Sergi
    Luis Lanciego, Jose
    Mueller, Christa E.
    Franco, Rafael
    PHARMACOLOGY & THERAPEUTICS, 2011, 132 (03) : 280 - 299
  • [7] Adenosine, adenosine A2A antagonists, and Parkinson's disease
    Jenner, P.
    Mori, A.
    Hauser, R.
    Morelli, M.
    Fredholm, B. B.
    Chen, J. F.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (06) : 406 - 413
  • [8] Adenosine A2A Receptor Antagonists as a Treatment Option for Parkinson's Disease?
    Jost, Wolfgang H.
    Toenges, Lars
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2022, 90 (12) : 565 - 570
  • [9] Novel therapy in Parkinson's disease: adenosine A2A receptor antagonists
    Szabo, Nikoletta
    Kincses, Zsigmond Tamas
    Vecsei, Laszlo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (04) : 441 - 455
  • [10] Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
    Xu, K
    Bastia, E
    Schwarzschild, M
    PHARMACOLOGY & THERAPEUTICS, 2005, 105 (03) : 267 - 310
12345